BRÈVE

sur Adesso AG (ETR:ADN1)

Adesso SE Reports 11% Sales Growth in Q1 2025 Amid Market Challenges

Graphique de l'évolution du cours de l'action Adesso AG (EBR:ADN1).

Adesso SE announced an 11% rise in sales to EUR 353.4 million in Q1 2025, continuing its growth trajectory despite a challenging macroeconomic environment. The company's EBITDA remained stable at EUR 17.8 million, supported by other operating income. Improved capacity utilization and market growth are expected to boost earnings throughout the year.

Adesso faced a subdued Q1 due to public sector delays from recent elections. Employment increased by 5% to 10,461 FTEs, but the rise in personnel costs was modest, aligning with sales growth. Material costs grew 27% to EUR 53.9 million due to increased external staffing.

Growth was notable in the healthcare sector with a 37% sales increase, and the utilities sector saw a 25% increase. Germany's market grew by 13%, while international sales rose by 5%, although performance varied across countries.

R. P.

Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de Adesso AG